Sequencing the oligosaccharide pool in the low molecular weight heparin dalteparin with offline HPLC and ESI-MS/MS.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Carbohydrate Polymers

• Publication date

  2018-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.carbpol.2017.11.039PMID 29352895
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structural Characterization of the Low-Molecular-Weight Heparin Dalteparin by Combining Different Analytical Strategies

  2017cited by this paper
• Hydrophilic interaction chromatography-multiple reaction monitoring mass spectrometry method for basic building block analysis of low molecular weight heparins prepared through nitrous acid depolymerization.

  2017cited by this paper
• Synthesis of 3-O-Sulfated Oligosaccharides to Understand the Relationship between Structures and Functions of Heparan Sulfate.

  2017cited by this paper
• Capillary Electrophoresis-Mass Spectrometry for the Analysis of Heparin Oligosaccharides and Low Molecular Weight Heparin.

  2016cited by this paper
• Comprehensive Identification and Quantitation of Basic Building Blocks for Low-Molecular Weight Heparin.

  2016cited by this paper
• Analytical and statistical comparability of generic enoxaparins from the US market with the originator product.

  2015cited by this paper
• Fragment profiling of low molecular weight heparins using reversed phase ion pair liquid chromatography-electrospray mass spectrometry.

  2015cited by this paper
• Liquid chromatography-diode array detection-mass spectrometry for compositional analysis of low molecular weight heparins.

  2014cited by this paper
• Bottom-Up Low Molecular Weight Heparin Analysis Using Liquid Chromatography-Fourier Transform Mass Spectrometry for Extensive Characterization

  2014cited by this paper
• Low molecular weight heparin

  2014cited by this paper
• Mapping of low molecular weight heparins using reversed phase ion pair liquid chromatography-mass spectrometry.

  2014cited by this paper
• Scientific considerations in the review and approval of generic enoxaparin in the United States

  2013cited by this paper
• Structural analysis of low molecular weight heparin by ultraperformance size exclusion chromatography/time of flight mass spectrometry and capillary zone electrophoresis.

  2013cited by this paper
• Structurally Informative Tandem Mass Spectrometry of Highly Sulfated Natural and Chemoenzymatically Synthesized Heparin and Heparan Sulfate Glycosaminoglycans*

  2013cited by this paper
• Novel reverse-phase ion pair-high performance liquid chromatography separation of heparin, heparan sulfate and low molecular weight-heparins disaccharides and oligosaccharides.

  2013cited by this paper
• Top-down approach for the direct characterization of low molecular weight heparins using LC-FT-MS.

  2012cited by this paper
• GlycReSoft: A Software Package for Automated Recognition of Glycans from LC/MS Data

  2012cited by this paper
• Structural elucidation of the tetrasaccharide pool in enoxaparin sodium

  2012cited by this paper
• Complete mass spectral characterization of a synthetic ultralow-molecular-weight heparin using collision-induced dissociation.

  2012cited by this paper
• Disaccharide compositional analysis of heparan sulfate and heparin polysaccharides using UV or high-sensitivity fluorescence (BODIPY) detection

  2010cited by this paper
• Structural features of low-molecular-weight heparins affecting their affinity to antithrombin

  2009cited by this paper
• Heparins: Process-related physico-chemical and compositional characteristics, fingerprints and impurities

  2009cited by this paper
• Analysis of oligosaccharides derived from heparin by ion-pair reversed-phase chromatography/mass spectrometry.

  2009cited by this paper
• Heparin and low-molecular-weight heparin

  2008cited by this paper
• Low Molecular Weight Heparins: Structural Differentiation by Bidimensional Nuclear Magnetic Resonance Spectroscopy

  2007cited by this paper
• Distinguishing glucuronic from iduronic acid in glycosaminoglycan tetrasaccharides by using electron detachment dissociation.

  2007cited by this paper
• Heparin induced thrombocytopenia: diagnosis and management update

  2007cited by this paper
• Chromatographic analysis and sequencing approach of heparin oligosaccharides using cetyltrimethylammonium dynamically coated stationary phases.

  2004cited by this paper
• Heparin Enhances the Specificity of Antithrombin for Thrombin and Factor Xa Independent of the Reactive Center Loop Sequence

  2001cited by this paper
• Microanalysis of glycosaminoglycan-derived oligosaccharides labeled with a fluorophore 2-aminobenzamide by high-performance liquid chromatography: application to disaccharide composition analysis and exosequencing of oligosaccharides.

  1999cited by this paper
• Sequencing complex polysaccharides.

  1999cited by this paper
• Determination of constituents of sulphated proteoglycans using a methanolysis procedure and gas chromatography/mass spectrometry of heptafluorobutyrate derivatives

  1999cited by this paper
• Heparins, Low-Molecular-Weight Heparins, and Other Glycosaminoglycans Analyzed by Agarose Gel Electrophoresis and Azure A-Silver Staining

  1997cited by this paper
• Separation of glycosaminoglycan-derived oligosaccharides by capillary electrophoresis using reverse polarity.

  1994cited by this paper
• Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives.

  1992cited by this paper

• Enzyme-assisted structural characterization of ulvan from Ulva pertusa by hydrophilic interaction liquid chromatography coupled with mass spectrometry.

  2025cites this paper
• Immobilized high-performance heparin lyase III for efficient preparation of low molecular weight heparin.

  2024cites this paper
• Pseudomorphic synthesis of pore size-tunable mesoporous silica spherical particles and their application for the fraction of low-molecular-weight heparin.

  2024cites this paper
• Low molecular weight heparin promotes the PPAR pathway by protecting the glycocalyx of cells to delay the progression of diabetic nephropathy

  2024cites this paper
• Characterization of maltose‐binding protein–fused heparinases with enhanced thermostability by application of rigid and flexible linkers

  2024cites this paper
• Investigating the Anticancer Effects of Pleurotus ostreatus Polysaccharide on G0/G1 Cell Cycle Arrest and Apoptosis in Ehrlich Ascites Carcinoma Cells

  2024cites this paper
• Structurally defined heparin octasaccharide domain for binding to SARS-CoV-2 Omicron BA.4/BA.5/BA.5.2 spike protein RBD.

  2023cites this paper
• Production, characteristics and applications of microbial heparinases.

  2022cites this paper
• A Cluster Sequencing Strategy To Determine the Consensus Affinity Domains in Heparin for Its Binding to Specific Proteins.

  2022cites this paper
• Alginate oligosaccharides: The structure-function relationships and the directional preparation for application.

  2022cites this paper
• Recent advances on the one-pot synthesis to assemble size-controlled glycans and glycoconjugates and polysaccharides.

  2021cites this paper
• Analysis of heparinase derived LMWH products using a MHC 2D LC system linked to Q-TOF MS.

  2021cites this paper
• Coupling Liquid Chromatography and Tandem Mass Spectrometry to Electrophoresis for In-Depth Analysis of Glycosaminoglycan Drugs: Heparin and the Multicomponent Sulodexide.

  2020cites this paper
• Discovery of exolytic heparinases and their catalytic mechanism and potential application

  2020cites this paper
• Recent advances in biotechnology for heparin and heparan sulfate analysis.

  2020cites this paper
• Preparation of alginate oligosaccharides and their biological activities in plants: A review.

  2020cites this paper
• Enzymatic depolymerization of streptococcus pneumoniae type 8 polysaccharide.

  2020cites this paper
• Polysaccharide κ-Carrageenan as Doping Agent in Conductive Coatings for Electrochemical Controlled Release of Dexamethasone at Therapeutic Doses

  2020cites this paper
• Shotgun ion mobility mass spectrometry sequencing of heparan sulfate saccharides

  2020cites this paper
• Heparanase as an Additional Tool for Detecting Structural Peculiarities of Heparin Oligosaccharides

  2019cites this paper
• Salt-free fractionation of complex isomeric mixtures of glycosaminoglycan oligosaccharides compatible with ESI-MS and microarray analysis

  2019influential citation
• Sequencing Heparan Sulfate Using HILIC LC-NETD-MS/MS.

  2019cites this paper
• Characterization of epimerization and composition of heparin and dalteparin using a UHPLC-ESI-MS/MS method.

  2019cites this paper
• Analysis of sulfates on low molecular weight heparin using mass spectrometry: structural characterization of enoxaparin

  2018cites this paper
• Qualitative and quantitative analysis of 2, 5-anhydro-d-mannitol in low molecular weight heparins with high performance anion exchange chromatography hyphenated quadrupole time of flight mass spectrometry.

  2018cites this paper